<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"></head><body style="word-wrap: break-word; -webkit-nbsp-mode: space; line-break: after-white-space;" class=""><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><b class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Washington Trade Daily<u class=""></u><u class=""></u></span></b></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Volume 31, Number 244 Friday, December 9, 2022<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 14pt; font-family: "Times New Roman", serif;" class="">TRIPS Decision May Be Delayed til June<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 14pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Geneva – The much-anticipated outcome to extend the World Trade Organization’s 12th<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">ministerial conference TRIPS decision to COVID-19 diagnostics and therapeutics by December 17 may<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">be deferred to June 30, 2023, raising serious doubts on the credibility and integrity of the MC12<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">decisions, WTD has learned.<br class=""><br class=""><u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">In a restricted Job document (Job/IP/65) issued on December 7, TRIPS Council Chair<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Ambassador Lansana Gberie of Sierra Leone submitted a draft report to the General Council stating that<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">“there is currently no consensus among Members to take a decision under paragraph 8 of the Decision”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">of the TRIPS Agreement.<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Ambassador Gberie says that, due to continued differences on finalizing a decision as per<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">paragraph eight that requires members to conclude a decision to extend the TRIPS Agreement Decision<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">to COVID-19 diagnostics and therapeutics, “members agree to continue discussions in the TRIPS<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Council and to report to the General Council no later than 30 June 2023.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">No Final Decision<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">However, members have not given a nod to the chair’s proposal, and it remains to be seen<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">whether members will agree to the new deadline, said a TRIPS negotiator who preferred not to be<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">identified.<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">In his report, the chair says “since the adoption of the Decision, Members have held discussions<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">in this regard in formal and informal meetings of the TRIPS Council on 6 July, on 19 September, on<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">3 and 12-13 October, on 2 and 22 November, and on 6 [and 15] December 2022.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">He says delegations “have exchanged views, asked questions, and provided responses,<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">clarifications, and information, including through new submissions circulated as documents RD/IP/49,<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">IP/C/W/693, RD/IP/51 and IP/C/W/694.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Many developing and least-developed countries proposed a draft decision in IP/C/W/694 of<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">6 December, stating that the Decision on the TRIPS Agreement adopted on 17 June is “far removed<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">from the comprehensive TRIPS waiver proposal contained in documents IP/C/W/669 and<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">IP/C/W/669/Rev/1 (“original TRIPS waiver proposal”) co-sponsored by 65 WTO members<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">(co-sponsors).”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Some Want Decision Now<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">The co-sponsors, including Argentina, Bangladesh, Bolivia, Egypt, India, Indonesia, Pakistan,<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">South Africa and Venezuela, maintained that “a more comprehensive waiver decision as envisaged in<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">the original TRIPS waiver proposal would support the efforts to ensure timely, equitable and universal<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">access to safe, affordable and effective therapeutics and diagnostics, ramping up of production and<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">expanding supply options.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">They argued that the “MC12 Ministerial Decision on the TRIPS Agreement (document<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">WT/MIN (22)/30) is the result of over one and half years of arduous and lengthy discussions on the<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">original TRIPS waiver proposal and intense negotiations heading towards the 12th Ministerial<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Conference in the midst of a global crisis” and “it is of limited scope covering only vaccines.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">More importantly, they said, “diagnostics and therapeutics are essential tools for a<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">comprehensive approach to fight the pandemic, that it is not over.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Against this backdrop, “omitting these vital tools will deter the effectiveness of the decision that<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">aims timely and affordable access to effective vaccines against the ongoing COVID-19 pandemic,” the<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">co-sponsors said.<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">“At a minimum,” the co-sponsors emphasized, “the extension of the policy tools provided in<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">document WT/MIN/(22)/30 to therapeutics and diagnostics will result in a holistic approach to enable<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">developing countries to address IP (intellectual property) barriers that prevent the expansion and<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">diversification of production and increase accessibility to crucial life-saving COVID-19 tools.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Further, “the current outcome represents a narrow-conditioned Decision due to demands of<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">some WTO members, requiring significant compromises on the part of the co-sponsors that had hoped<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">for greater solidarity among WTO members during a public health emergency and consequently a more<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">comprehensive waiver decision as envisaged in the original TRIPS waiver proposal that would support<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">ramping up of production and expanding supply options.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">The co-sponsors called on the General Council, which is scheduled to meet on December 19, “to<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">immediately extend the 17 June TRIPS Decision adopted by the Ministers by<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">consensus after long protracted negotiations, mutatis mutandis to therapeutics and diagnostics.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">“WTO Members have an opportunity to show they can act promptly to respond to the ongoing<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">COVID-19 pandemic and the challenge of inequitable access to therapeutics and diagnostics and<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">respond to the criticism that the Decision on vaccines came too little too late,” they said.<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Decision Text Submitted<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">The co-sponsors submitted a “Decision Text” for the General Council to adopt on December 19.<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Ambassador Gberie maintained that “ delegations engaged actively and their detailed<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">substantive exchanges helped clarify various aspects and nuances of positions.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Without naming the countries, the chair says “while delegations remain committed to the<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">common goal of providing timely and secure access to high-quality, safe, efficacious and affordable<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">medical technologies for all, disagreement persists on whether an extension of the Decision to cover the<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">production and supply of COVID-19 diagnostics and therapeutics is necessary or appropriate to address<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">any inequitable distribution of such COVID-19 related products.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class=""><u class=""></u> <u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">The chair says “on 6 December 2022 a group of Members tabled a proposal for the General<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">Council to extend the Decision mutatis mutandis to COVID-19 therapeutics and diagnostics.”<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">According to Ambassador Gberie, “other Members preferred to continue fact- and<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">evidence-based discussions on whether there are IP- and TRIPS-related barriers to </span><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">accessing<u class=""></u><u class=""></u></span></div><div style="margin: 0px; caret-color: rgb(34, 34, 34); color: rgb(34, 34, 34); font-family: Arial, Helvetica, sans-serif;" class=""><span style="font-size: 12pt; font-family: "Times New Roman", serif;" class="">COVID-19 therapeutics and diagnostics, and on the exact scope of a potential extension of the Decision.”</span></div></body></html>